These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 24598771)
1. GRK5 dysfunction accelerates tau hyperphosphorylation in APP (swe) mice through impaired cholinergic activity. Zhang Y; Chen L; Shen G; Zhao Q; Shangguan L; He M Neuroreport; 2014 May; 25(7):542-7. PubMed ID: 24598771 [TBL] [Abstract][Full Text] [Related]
2. GRK5 influences the phosphorylation of tau via GSK3β and contributes to Alzheimer's disease. Zhao J; Li X; Chen X; Cai Y; Wang Y; Sun W; Mai H; Yang J; Fan W; Tang P; Ou M; Zhang Y; Huang X; Zhao B; Cui L J Cell Physiol; 2019 Jul; 234(7):10411-10420. PubMed ID: 30511419 [TBL] [Abstract][Full Text] [Related]
3. GRK5 deficiency accelerates {beta}-amyloid accumulation in Tg2576 mice via impaired cholinergic activity. Cheng S; Li L; He S; Liu J; Sun Y; He M; Grasing K; Premont RT; Suo WZ J Biol Chem; 2010 Dec; 285(53):41541-8. PubMed ID: 21041302 [TBL] [Abstract][Full Text] [Related]
4. GRK5 deficiency leads to reduced hippocampal acetylcholine level via impaired presynaptic M2/M4 autoreceptor desensitization. Liu J; Rasul I; Sun Y; Wu G; Li L; Premont RT; Suo WZ J Biol Chem; 2009 Jul; 284(29):19564-71. PubMed ID: 19478075 [TBL] [Abstract][Full Text] [Related]
5. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation. Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757 [TBL] [Abstract][Full Text] [Related]
6. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice. Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430 [TBL] [Abstract][Full Text] [Related]
7. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study. Zhang ZX; Zhao RP; Wang DS; Wang AN Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601 [TBL] [Abstract][Full Text] [Related]
8. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. Rockenstein E; Torrance M; Adame A; Mante M; Bar-on P; Rose JB; Crews L; Masliah E J Neurosci; 2007 Feb; 27(8):1981-91. PubMed ID: 17314294 [TBL] [Abstract][Full Text] [Related]
10. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice. Jin G; Wang LH; Ji XF; Chi TY; Qi Y; Jiao Q; Xu Q; Zhou XY; Zhang R; Zou LB Neurosci Lett; 2014 Jun; 573():58-63. PubMed ID: 24810883 [TBL] [Abstract][Full Text] [Related]
12. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model. Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967 [TBL] [Abstract][Full Text] [Related]
13. Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice. Hu Y; Lai J; Wan B; Liu X; Zhang Y; Zhang J; Sun D; Ruan G; Liu E; Liu GP; Chen C; Wang DW Neurotoxicology; 2016 Mar; 53():290-300. PubMed ID: 26945731 [TBL] [Abstract][Full Text] [Related]
14. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589 [TBL] [Abstract][Full Text] [Related]
15. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease. Zhu C; Xu B; Sun X; Zhu Q; Sui Y Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757 [TBL] [Abstract][Full Text] [Related]
16. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice. Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318 [TBL] [Abstract][Full Text] [Related]
18. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736 [TBL] [Abstract][Full Text] [Related]
19. [Puerarin alleviates cognitive impairment and tau hyperphosphorylation in APP/PS1 transgenic mice]. Mei ZR; Tan XP; Liu SZ; Huang HH Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(17):3285-3289. PubMed ID: 28920384 [TBL] [Abstract][Full Text] [Related]
20. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells. Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]